Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Preclinical Tomography System Market by Type (CT, PET&SPECT, Composite System), By Application (Biopharmaceuticals, Research Institute, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Preclinical Tomography System Market by Type (CT, PET&SPECT, Composite System), By Application (Biopharmaceuticals, Research Institute, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 136854 3300 Medical Devices & Consumables 377 235 Pages 5 (40)

Market Overview:

The global preclinical tomography system market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for preclinical tomography systems from biopharmaceutical companies and research institutes across the globe. In addition, the growing adoption of composite systems is also contributing to the growth of this market. However, factors such as high cost and lack of skilled professionals are restraining the growth of this market. On the basis of type, CT scanners accounted for a major share in 2017 and are expected to continue its dominance during the forecast period. This can be attributed to their ability to provide high-resolution images with good contrast resolution that helps in accurate diagnosis and treatment planning for various diseases.

Global Preclinical Tomography System Industry Outlook

Product Definition:

Preclinical tomography system is a medical imaging technique that uses X-rays to produce three-dimensional images of the inside of an object. It is used to diagnose and treat medical conditions.


CT or computed tomography is a diagnostic medical imaging technology that utilizes X-rays to produce 3D images of internal body organs and tissues. CT scans are painless, require little to no radiation exposure, and can provide detailed information on the structure and function of complex organs.


PET & SPECT are two different Tomography systems used in preclinical imaging. PET is an expensive and complex system which helps in studying molecular mechanisms whereas the simpler and cost-effective spectroscopic imaging technique, known as Single Photon Emission Computed Tomography (SPECT) is used for clinical purposes.

Application Insights:

The biopharmaceuticals segment dominated the global preclinical tomography system market in terms of revenue in 2017. The growth can be attributed to the increasing usage of these systems for drug development and testing. Preclinical imaging helps visualize tissue morphology, composition, and physiology during various stages of clinical trials. It also provides information about tumor biology including proliferation rates, metastasis potential, angiogenesis ability & activity as well as invasiveness. These factors are taken into consideration while designing future trials for cancer treatment or diagnosis purposes.

CT is widely used for preclinical imaging due to its ability to provide detailed images of soft tissue structures with high spatial resolution than other modalities such as MRI or ultrasound does at a cheaper cost compared to these devices (composite).

Regional Analysis:

North America dominated the global preclinical tomography system market in 2017. This can be attributed to the presence of a large number of players, high adoption rate for new technologies, and increasing R&D expenditure by companies. The region is expected to maintain its dominance throughout the forecast period owing to continuous technological advancements and growing biopharmaceutical industry in this region. Asia Pacific is anticipated to grow at a lucrative CAGR during the forecast period due to increasing government funding for medical & healthcare research projects along with rising awareness about clinical trials in emerging countries such as China & India.

Major players operating in this industry include GE Healthcare; Siemens Healthineers; Philips Healthcare; PerkinElmer Inc.; Hitachi, Ltd.; Toshiba Medical Systems Corporation; Koninklijke Philips N.V.

Growth Factors:

  • Increasing demand for better and faster drug discovery and development processes is expected to drive the Preclinical Tomography System market growth.
  • The increasing use of preclinical tomography systems for 3D cell culture analysis is also anticipated to fuel the market growth in the near future.
  • Rising number of research institutes and universities are expected to create new opportunities for the Preclinical Tomography System market in coming years.
  • Growing investments by key players in R&D activities is likely to propel the Preclinical Tomography System market growth over the forecast period.

Scope Of The Report

Report Attributes

Report Details

Report Title

Preclinical Tomography System Market Research Report

By Type

CT, PET&SPECT, Composite System

By Application

Biopharmaceuticals, Research Institute, Other

By Companies

Bruker, SEDECAL, MR Solutions, Scanco Medical, PerkinElmer, Mediso, MILabs, Trifoil Imaging

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Preclinical Tomography System Market Report Segments:

The global Preclinical Tomography System market is segmented on the basis of:


CT, PET&SPECT, Composite System

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Biopharmaceuticals, Research Institute, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Bruker
  3. MR Solutions
  4. Scanco Medical
  5. PerkinElmer
  6. Mediso
  7. MILabs
  8. Trifoil Imaging

Global Preclinical Tomography System Market Overview

Highlights of The Preclinical Tomography System Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. CT
    2. PET&SPECT
    3. Composite System
  1. By Application:

    1. Biopharmaceuticals
    2. Research Institute
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Preclinical Tomography System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Preclinical Tomography System Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

A preclinical tomography system (CT) is a medical imaging device that uses X-rays to create images of the body. CT scans are used to diagnose and monitor diseases, injuries, and other conditions in the body.

Some of the major companies in the preclinical tomography system market are Bruker, SEDECAL, MR Solutions, Scanco Medical, PerkinElmer, Mediso, MILabs, Trifoil Imaging.

The preclinical tomography system market is expected to grow at a compound annual growth rate of 7.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Preclinical Tomography System Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Preclinical Tomography System Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Preclinical Tomography System Market - Supply Chain
   4.5. Global Preclinical Tomography System Market Forecast
      4.5.1. Preclinical Tomography System Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Preclinical Tomography System Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Preclinical Tomography System Market Absolute $ Opportunity

5. Global Preclinical Tomography System Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Preclinical Tomography System Market Size and Volume Forecast by Type
      5.3.1. CT
      5.3.2. PET&SPECT
      5.3.3. Composite System
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Preclinical Tomography System Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Preclinical Tomography System Market Size and Volume Forecast by Application
      6.3.1. Biopharmaceuticals
      6.3.2. Research Institute
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Preclinical Tomography System Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Preclinical Tomography System Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Preclinical Tomography System Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Preclinical Tomography System Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Preclinical Tomography System Demand Share Forecast, 2019-2029

9. North America Preclinical Tomography System Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Preclinical Tomography System Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Preclinical Tomography System Market Size and Volume Forecast by Application
      9.4.1. Biopharmaceuticals
      9.4.2. Research Institute
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Preclinical Tomography System Market Size and Volume Forecast by Type
      9.7.1. CT
      9.7.2. PET&SPECT
      9.7.3. Composite System
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Preclinical Tomography System Demand Share Forecast, 2019-2029

10. Latin America Preclinical Tomography System Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Preclinical Tomography System Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Preclinical Tomography System Market Size and Volume Forecast by Application
      10.4.1. Biopharmaceuticals
      10.4.2. Research Institute
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Preclinical Tomography System Market Size and Volume Forecast by Type
      10.7.1. CT
      10.7.2. PET&SPECT
      10.7.3. Composite System
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Preclinical Tomography System Demand Share Forecast, 2019-2029

11. Europe Preclinical Tomography System Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Preclinical Tomography System Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Preclinical Tomography System Market Size and Volume Forecast by Application
      11.4.1. Biopharmaceuticals
      11.4.2. Research Institute
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Preclinical Tomography System Market Size and Volume Forecast by Type
      11.7.1. CT
      11.7.2. PET&SPECT
      11.7.3. Composite System   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Preclinical Tomography System Demand Share, 2019-2029

12. Asia Pacific Preclinical Tomography System Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Preclinical Tomography System Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Preclinical Tomography System Market Size and Volume Forecast by Application
      12.4.1. Biopharmaceuticals
      12.4.2. Research Institute
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Preclinical Tomography System Market Size and Volume Forecast by Type
      12.7.1. CT
      12.7.2. PET&SPECT
      12.7.3. Composite System
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Preclinical Tomography System Demand Share, 2019-2029

13. Middle East & Africa Preclinical Tomography System Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Preclinical Tomography System Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Preclinical Tomography System Market Size and Volume Forecast by Application
      13.4.1. Biopharmaceuticals
      13.4.2. Research Institute
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Preclinical Tomography System Market Size and Volume Forecast by Type
      13.7.1. CT
      13.7.2. PET&SPECT
      13.7.3. Composite System
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Preclinical Tomography System Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Preclinical Tomography System Market: Market Share Analysis
   14.2. Preclinical Tomography System Distributors and Customers
   14.3. Preclinical Tomography System Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Bruker Overview Financials Developments Strategic Outlook
      14.4.2. SEDECAL Overview Financials Developments Strategic Outlook
      14.4.3. MR Solutions Overview Financials Developments Strategic Outlook
      14.4.4. Scanco Medical Overview Financials Developments Strategic Outlook
      14.4.5. PerkinElmer Overview Financials Developments Strategic Outlook
      14.4.6. Mediso Overview Financials Developments Strategic Outlook
      14.4.7. MILabs Overview Financials Developments Strategic Outlook
      14.4.8. Trifoil Imaging Overview Financials Developments Strategic Outlook
      14.4.9. COMPANY9 Overview Financials Developments Strategic Outlook
      14.4.10. COMPANY 10 Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us